Orchestra BioMed

About:

Orchestra BioMed is a biomedical innovation company that provides high-impact solutions for large unmet needs in procedure-based medicine.

Website: https://www.orchestrabiomed.com/

Twitter/X: OrchestraBioMed

Top Investors: Perceptive Advisors, Medtronic, RTW Investments, Soleus Capital, Terumo Corporation

Description:

Orchestra BioMed, Inc. is a biomedical innovation company focused on developing high impact, high value, evidence-based therapeutic solutions for medical procedures that address major medical conditions. Its main focus is on developing new therapies for cardiovascular diseases which are the leading cause of death worldwide, taking the lives of 17.7 million people each year, or 31% of all global deaths according to the World Health Organization. It was founded in 2017 and is headquartered in New Hope, Pennsylvania.

Total Funding Amount:

$283M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

New Hope, Pennsylvania, United States

Founded Date:

2017-01-01

Contact Email:

info(AT)orchestrabiomed.com

Founders:

Darren Sherman

Number of Employees:

51-100

Last Funding Date:

2022-07-05

IPO Status:

Public

Industries:

© 2025 bioDAO.ai